Concise Manual of Hematology and Oncology

  • Dietmar P. Berger
  • Monika Engelhardt
  • Hartmut Henß
  • Roland Mertelsmann

Table of contents

  1. Front Matter
    Pages I-XXI
  2. Dietmar P. Berger, Hartmut Henß, Uwe Martens, Hartmut Bertz, Monika Engelhardt, Sebastian Fetscher
    Pages 1-38
  3. Regina Kunzmann, Michael Luebbert, Hendrik Veelken, Jürgen Scheele, Uwe Martens, Rupert Engelhardt et al.
    Pages 39-64
  4. Dietmar P. Berger, Rupert Engelhardt, Hartmut Henß, Jürgen Scheele, Claudia I. Müller, Alexandra Göbel et al.
    Pages 65-203
  5. Michael Daskalakis, Hartmut Bertz, Veronique Thierry, Claudia I. Müller, Monika Engelhardt, Antonia Müller et al.
    Pages 204-292
  6. Barbara Deschler, Cornelius Waller, Monika Engelhardt, Antonia Müller, Michael Luebbert, Jürgen Finke et al.
    Pages 293-326
  7. Jürgen Finke, Hartmut Bertz, Anna-Katharina Kaskel, Jürgen Heinz, A.K. Thomas, Dietmar P. Berger et al.
    Pages 327-399
  8. Ralph Waesch, Werner Digel, Michael Luebbert, Kristina Heining-Mikesch, Cornelius Waller, W. Lange et al.
    Pages 400-526
  9. Michael Daskalakis, Karl Henne, Hartmut Henß, Uwe Martens, Werner Digel, Rupert Engelhardt et al.
    Pages 528-780
  10. Hartmut Bertz, Hartmut Henß, Beate Lubrich
    Pages 781-801
  11. Rupert Engelhardt, Andrea Engelhardt, Frank Gärtner, Stephan Mielke, Uwe Frank
    Pages 802-822
  12. D. Behringer, Dietmar P. Berger, Werner Digel, Monika Engelhardt, Jürgen Finke, Hartmut Bertz et al.
    Pages 823-989
  13. Back Matter
    Pages 991-1002

About this book

Introduction

How Do We Treat? Hematology and Oncology have seen rapid progress and advances during recent years. Increased knowledge of tumor biology, epidemiology, molecular genetics, growth reg- lation, and cellular functions has led to novel therapeutic paradigms. Targeted trea- ment approaches, antibodies, immunotherapy, and other new techniques complement classic chemotherapy, radiotherapy, and surgery. Patients are increasingly well educated as web-based information on diagnostic and therapeutic options as well as quality ma- agement and tumor outcome data are readily available. In this dynamic and fast-paced environment, it is of central importance to base clinical decisions and medical practice on the best available evidence. Continuous quality ma- agement, with clinical process documentation, standardization, and evaluation, leads to improved patient care and long-term outcomes. For these reasons, we have started to systematically capture and evaluate data on diagnosis, treatment, and outcomes of p- tients with solid tumors and hematological neoplasms at the Freiburg University Med- cal Center. We have developed standard operating procedures, clinical pathways, and diagnostic and therapeutic processes, following the principles of “Good Clinical Pra- tice.” Tese processes (e.g., detailed protocols for chemotherapy application, treatment fowcharts, clinical pathways) are continuously tested and validated in clinical practice.

Keywords

Cancer Chemotherapy Hematology Oncology diagnostics

Editors and affiliations

  • Dietmar P. Berger
    • 1
  • Monika Engelhardt
    • 1
  • Hartmut Henß
    • 2
  • Roland Mertelsmann
    • 1
  1. 1.Department of Hematology and OncologyUniversity Medical CenterFreiburgGermany
  2. 2.Tumorzentrum Ludwig-Heilmeyer, Comprehensive Cancer CenterUniversity Medical CenterFreiburgGermany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-540-73277-8
  • Copyright Information Springer Berlin Heidelberg 2008
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Medicine
  • Print ISBN 978-3-540-73276-1
  • Online ISBN 978-3-540-73277-8
  • About this book